Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KP TissueKPTSF 28 Equity-to-Asset is 0.97 as of Jun. 2026, which is 1% above its 10-year median of 0.96. GuruFocus rates KPTSF with a GF Score™ of 28/100. The stock has 6 warning signs investors should review. Among 1,994 Consumer Packaged Goods companies, KP Tissue ranks better than 99.2% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. KP Tissue's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $51.82 Mil. KP Tissue's Total Assets for the quarter that ended in Jun. 2026 was $53.32 Mil.
The historical rank and industry rank for KP Tissue's Equity-to-Asset or its related term are showing as below:
KPTSF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.9 Med: 0.96 Max: 0.98
Current: 0.97
During the past 13 years, the highest Equity to Asset Ratio of KP Tissue was 0.98. The lowest was 0.90. And the median was 0.96.
KPTSF's Equity-to-Asset is ranked better than 99.2% of 1994
companies
in the Consumer Packaged Goods industry
Industry Median: 0.55
vs KPTSF: 0.97
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
KP Tissue Equity-to-Asset Related Terms
KP Tissue Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for KP Tissue's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, KP Tissue's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KP Tissue Equity-to-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, KP Tissue's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where KP Tissue's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
KP Tissue's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KP Tissue (KPTSF) has a Equity-to-Asset of 0.97 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on KP Tissue and its competitors. This is near median its historical median of 0.96. Over the past decade, KP Tissue's Equity-to-Asset has ranged from 0.90 to 0.98. According to the industry distribution chart, KP Tissue ranks #16 out of 1994 companies in the Consumer Packaged Goods industry, placing it in the top 0.8%.
Is KP Tissue's Equity-to-Asset too high?
KP Tissue's current Equity-to-Asset of 0.97 is near median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 0.98. The Consumer Packaged Goods industry median Equity-to-Asset is 0.55. KP Tissue's value of 0.97 is 76.4% above this industry median. Based on the distribution chart, KP Tissue ranks #16 out of 1994 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, KP Tissue has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does KP Tissue's Equity-to-Asset compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, KP Tissue ranks #16 out of 1994 companies for Equity-to-Asset. This places KP Tissue in the top 1% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.55. KP Tissue's value of 0.97 is 76.4% above this benchmark. Historically, KP Tissue's own Equity-to-Asset has ranged from 0.90 to 0.98 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 0.55, KP Tissue has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Consumer Packaged Goods company?
The median Equity-to-Asset among Consumer Packaged Goods companies is 0.55, based on 1,994 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KP Tissue's current Equity-to-Asset of 0.97 is 76.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on KP Tissue and its competitors. For the Consumer Packaged Goods industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KP Tissue's current Equity-to-Asset is 0.97, which is near median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KP Tissue stock overvalued right now?
KP Tissue (KPTSF) has a current Equity-to-Asset of 0.97. The current Equity-to-Asset is 0.97, which is near median its 10-year median of 0.96 and 76.4% above the Consumer Packaged Goods industry median of 0.55. KP Tissue's overall GF Score™ is 28/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For KP Tissue (KPTSF), the current Equity-to-Asset is 0.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. The products are marketed under several trademarks, such as Cashmere, Purex, SpongeTowels, Esteem, White Swan, Embassy, and others. A majority of its revenue is generated from the sale of tissue products in the consumer market. Geographically, the company derives maximum revenue from Canada and the rest from the United States.
28GF Score
Get the complete analysis for KPTSF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KPTSF has been successfully added to your 
